Evidence map›Paper›PMID 39111286›Full record

ArticleCell metabolism2024

Intermittent clearance of p21-highly-expressing cells extends lifespan and confers sustained benefits to health and physical function.

Binsheng Wang, Lichao Wang, Nathan S Gasek, Chia-Ling Kuo, Jia Nie, Taewan Kim, Pengyi Yan, Junyu Zhu, Blake L Torrance, Yueying Zhou and 16 more

Abstract read
In one paragraph

Article in Cell metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. T cell senescence induced by DNMT1 deletion mediates cardiac transplant tolerance via altered CDKN1A methylation.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. CHK2-USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. p21Nature aging · 2026
    Article
  15. Redefining senescence through hepatocyte fate changes in liver diseases.Trends in endocrinology and metabolism: TEM · 2026
    Review
  16. Article
  17. Review
  18. Review
  19. Cellular sensor DAP5 decodesFrontiers in immunology · 2026
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Binsheng WangUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA.
Lichao WangUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA.
Nathan S GasekUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA.
Chia-Ling KuoUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Public Health Sciences, UConn Health, Farmington, CT 06030, USA.
Jia NieDivision of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Taewan KimUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA.
Pengyi YanUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA.
Junyu ZhuUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA.
Blake L TorranceUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Immunology, UConn Health, Farmington, CT 06030, USA.
Yueying ZhouUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Xiangya Stomatological Hospital, Central South University, Changsha, China.
Lisa C FloresSam and Ann Barshop Institute for Longevity and Aging Studies and Department of Pathology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Colton AllenSam and Ann Barshop Institute for Longevity and Aging Studies and Department of Pathology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Allison M AndradeUConn Center on Aging, UConn Health, Farmington, CT 06030, USA.
Chun GuoUConn Center on Aging, UConn Health, Farmington, CT 06030, USA.
Rachel L CohnUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA.
Evan R JellisonDepartment of Immunology, UConn Health, Farmington, CT 06030, USA.
Jenna M BartleyUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Immunology, UConn Health, Farmington, CT 06030, USA.
George A KuchelUConn Center on Aging, UConn Health, Farmington, CT 06030, USA.
Sheng LiThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06030, USA.
Tamar PirtskhalavaDivision of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Center for Advanced Gerotherapeutics, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Tamar TchkoniaDivision of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Center for Advanced Gerotherapeutics, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Sumit YadavDepartment of Growth and Development, UNMC College of Dentistry, Omaha, NE 68114, USA; Children's of Omaha - Children's Hospital, Omaha, NE 68114, USA.
Laura HaynesUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Immunology, UConn Health, Farmington, CT 06030, USA.
James L KirklandDivision of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Center for Advanced Gerotherapeutics, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Division of General Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Yuji IkenoSam and Ann Barshop Institute for Longevity and Aging Studies and Department of Pathology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Geriatric Research Education and Clinical Center (GRECC), Audie L. Murphy VA Hospital, South Texas Veterans Health Care System, San Antonio, TX 78229, USA.
Ming XuUConn Center on Aging, UConn Health, Farmington, CT 06030, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA. Electronic address: mixu@uchc.edu.

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI PETER J HORNSBY · 1995 to 2026
$30.6M
Targeting Cellular Senescence to Extend HealthspanP01AG062413 · NIA · MAYO CLINIC ROCHESTER · PI Sundeep Khosla · 2019 to 2026
$28.7M
San Antonio OAIC - Research Education Component (REC)P30AG044271 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Adam Salmon, Elena Volpi · 2015 to 2026
$14.1M
The Jackson Laboratory Senescence Tissue Mapping Center (JAX-Sen TMC) - Data Analysis CoreU54AG079753 · NIA · JACKSON LABORATORY · PI ROSENTHAL, NADIA A · 2022 to 2025
$11.0M
Research Education ComponentP30AG067988 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Richard H Fortinsky, GEORGE A KUCHEL · 2021 to 2026
$9.5M
Effect of Aging on Preadipocyte DifferentiationR37AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 2016 to 2025
$6.6M
Translational Geroscience NetworkR33AG061456 · NIA · MAYO CLINIC ROCHESTER · PI JAMES L. KIRKLAND, STEPHEN B. KRITCHEVSKY · 2019 to 2026
$6.2M
San Diego Nathan Shock CenterP30AG068635 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SHADEL, GERALD · 2020 to 2024
$6.0M
Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic DysfunctionR01AG068860 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI XU, MING, ZHOU, YANJIAO · 2020 to 2024
$2.8M
Targeting p21-Highly Expressing Cells to Increase Lifespan and Healthspan in Old AgeR01AG076642 · NIA · UNIVERSITY OF MINNESOTA · PI Ming Xu · 2022 to 2026
$2.4M
Targeting p21-positive Senescent Cells in vivo for Alleviating Metabolic and Physical DysfunctionR01AG066679 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI XU, MING · 2020 to 2024
$2.2M
NCI NIH HHS P30 CA034196NHGRI NIH HHS T32 HG010463NIA NIH HHS F30 AG081092NIA NIH HHS P01 AG062413NIA NIH HHS P30 AG013319NIA NIH HHS P30 AG044271NIA NIH HHS P30 AG067988NIA NIH HHS P30 AG068635NIA NIH HHS R01 AG066679NIA NIH HHS R01 AG068860NIA NIH HHS R01 AG076642NIA NIH HHS R03 AG072374NIA NIH HHS R21 AG071292NIA NIH HHS R33 AG061456NIA NIH HHS R37 AG013925NIA NIH HHS U54 AG079753
6 · The paper itself

Abstract

A key challenge in aging research is extending lifespan in tandem with slowing down functional decline so that life with good health (healthspan) can be extended. Here, we show that monthly clearance, starting from 20 months, of a small number of cells that highly express p21

Indexed as

Cyclin-Dependent Kinase Inhibitor p21LongevityMice, Inbred C57BLAgingAnimalsFemaleMaleMiceCdkn1a protein, mouseCyclin-Dependent Kinase Inhibitor p21agingcellular senescencefrailtyinflammationmorbidity compression

Identifiers

PMID39111286
PMCPMC11315361

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.